 |
|
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Clin Mol Hepatol. 2023;29(2):433-452. Published online 2023 Jan 4 DOI: https://doi.org/10.3350/cmh.2022.0316
|
|
Citations to this article as recorded by
 Acute rejection was observed in a combination therapy of CTLA-4 and PD-1 inhibitors before liver transplantation: A case report and literature review
Pengpeng Zhang, Tianyin Wang, Hong Liu, Xingguo She, Ke Chen, Yujun Zhao, Yingzi Ming
iLIVER.2023;[Epub] CrossRef The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 355. CrossRef The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clinical and Molecular Hepatology.2023; 29(2): 358. CrossRef Global trajectories of liver cancer burden from 1990 to 2019 and projection to 2035
Fan Yang, Dianqin Sun, Changfa Xia, He Li, Maomao Cao, Xinxin Yan, Siyi He, Shaoli Zhang, Wanqing Chen
Chinese Medical Journal.2023;[Epub] CrossRef
|